
Liver fibrosis drives outcomes in type 2 diabetes mellitus (T2DM), yet biopsy cannot screen everyone. We assessed whether fetuin-A and fibroblast growth factor-21 (FGF-21) track vibration-controlled transient elastography (VCTE)-defined liver stiffness, steatosis and body composition in Indian adults with T2DM attending a tertiary centre, and how FGF-21 compares with FIB-4, the currently recommended first-line test. In 150 consecutive adults with T2DM, fetuin-A and intact FGF-21 were measured by ELISA. Liver stiffness (LSM) and controlled attenuation parameter (CAP) were obtained by VCTE and body composition by dual-energy X-ray absorptiometry. Associations were tested with Spearman correlation; discrimination of LSM ≥ 8.0 kPa and LSM ≥ 9.6 kPa was assessed by ROC analysis with bootstrap internal validation and compared with FIB-4. Prespecified sensitivity analyses were restricted to the 116 participants meeting the CAP-based MASLD definition and stratified by sex. CAP-defined MASLD affected 77.3
Data-driven clustering has identified reproducible diabetes subtypes with distinct metabolic profiles and complication risks. However, their incremental prognostic value and clinical utility beyond conventional risk assessment remain uncertain. We conducted a systematic review and meta-analysis to evaluate associations between diabetes subtypes and long-term clinical outcomes in adults. PubMed/MEDLINE, Scopus, Web of Science, and the Cochrane Library were searched from inception through February 25, 2026, with an updated targeted literature search and citation/reference screening performed through August 2026. Observational cohort studies classifying adults with diabetes using data-driven clustering and reporting longitudinal kidney, cardiovascular, or mortality outcomes were included. Random-effects meta-analyses pooled study-reported hazard ratios (HRs), and narrative synthesis was conducted when pooling was not possible due to differences in comparator subtype, outcome definitions, or clustering frameworks. Thirty-four eligible study reports were included; 12 contributed to quantitative synthesis and 22 were synthesized narratively. Because several reports drew on overlapping source cohorts, a unique review-wide participant total was not calculated. Compared with mild age-related diabetes (MARD), severe insulin-resistant diabetes (SIRD) demonstrated the strongest associations with kidney outcomes, including CKD stage ≥3 (HR 1.84; 95
Although diabetes is linked to sleep disorders that can reduce quality of life (QOL) and increase depression risk, these conditions are still rarely assessed in clinical practice. This study aimed to evaluate sleep quality in older adults with type 2 diabetes (T2D) and its association with QOL and depressive symptoms. 151 individuals with T2D aged > 60 years without known sleep disorders underwent a review of clinical history and therapy, biochemical exams, and assessment of Pittsburgh Sleep Quality index (PSQI), World Health Organization QOL Bref (WHOQOL-BREF) scale, and Geriatric Depression Scale (GDS). The population was then split into: Good Sleepers (PSQI ≤ 5) and Poor Sleepers (PSQI > 5). The prevalence of low sleep quality was 63.6
To characterize metabolic and transcriptional alterations in diabetic kidney disease (DKD) and identify diagnostic biomarkers using a multi-omics approach. Mendelian randomization (MR) was used to assess causal relationships between metabolites and DKD. Renal transcriptomic datasets validated pathway and gene alterations. Machine learning models evaluated diagnostic performance, with SHAP for interpretation. Single-cell and spatial transcriptomics defined cell-specific expression patterns. In silico gene perturbation and in vitro validation in high-glucose–treated HK-2 cells were conducted. MR analysis identified 60 plasma metabolites whose genetically predicted levels showed evidence of association with DKD. These metabolites were enriched in one-carbon metabolism, histidine metabolism, and glycine, serine, and threonine metabolism, which showed consistent alterations in renal transcriptomic analyses. Machine learning models showed strong diagnostic performance (mean AUC = 0.963), with MAOA, CTH, and ALDH1L1 as key contributors. CTH was specifically expressed in proximal tubular cells and downregulated in injury-associated subpopulations. Functional analyses indicated that CTH affected epithelial integrity, mitochondrial metabolism, and immune responses, and was suppressed under high-glucose conditions. These findings provide insight into DKD pathogenesis and highlight CTH as a potential biomarker and therapeutic target.